Key stakeholders
These are the current top-level decision-makers at the company and their LinkedIn profiles. Check them for recent activity and updates
Latest news about Pfizer
Here are some of the most recent media mentions. Use them in your sales prospecting to qualify a prospect's buyer intent and personalize outreach with the latest company updates
Pfizer has discontinued the development of danuglipron, an oral GLP-1 receptor agonist for chronic weight management, due to a potential drug-induced liver injury despite meeting pharmacokinetic objectives and having a competitive efficacy and tolerability profile[1]. The ACIP has voted to expand the recommendation for Pfizer's RSV vaccine, ABRYSVO, to include adults aged 50-59 at increased risk of severe RSV-associated lower respiratory tract disease[2][4].
The U.S. Centers for Disease Control and Prevention’s Advisory Committee on Immunization Practices (ACIP) voted to expand the recommendation for Pfizer's RSV vaccine, ABRYSVO, to include adults aged 50-59 at increased risk of severe RSV-associated lower respiratory tract disease, building on the FDA's October 2024 approval for adults 18-59 at heightened risk[2][5].
Pfizer's RSV vaccine, ABRYSVO, has received an expanded recommendation from the ACIP to include adults aged 50-59 at increased risk of severe RSV-associated lower respiratory tract disease, following the FDA's October 2024 approval for adults 18-59 at heightened risk[2][4][5].
Open job positions at Pfizer
This company is actively hiring to fill these roles. Use this for sales prospecting if your solution assists, augments, or provides an alternative for the growing team and position.
Manager, Data Solutions Engineering
Senior Manager, AI and Analytics Data Engineer
Senior Manager, Data Science and AI Technical Product Owner